Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Real-World Cost-analysis of Paliperidone Palmitate for Schizophrenia Management:A Retrospective Analysis in Xiamen, China

Preprint in Research Square (April 2024)

Real-World Pharmacoeconomic Assessment of Paliperidone Palmitate for Schizophrenia Management:A Retrospective Analysis

Preprint in Research Square (September 2023)

Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans

Article in Journal of Managed Care & Specialty Pharmacy (March 2023)